Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$45.33M
↑ 120% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-228.96M
Historical baseline
PeriodValueYoY Change
TTM$45.33M+151.6%
2024$-87.87M+85.2%
2023$-594.74M-15.8%
2022$-513.75M+8.8%
2021$-563.13M-250.9%
2020$-160.49M+24.0%
2019$-211.13M-60.9%
2018$-131.24M-181.7%
2017$-46.60M-79.2%
2016$-26.00M-